Table 2. Adverse events of ⩾grade 3 experienced by patients during their monotherapy window, and concurrent chemotherapy treatment.
n=10 | |
---|---|
Lapatinib monotherapy | |
Lapatinib monotherapy toxicities | 0 |
Lapatinib and chemotherapy | |
Anastomotic leak | 2 |
Fainting | 1 |
Mucositis | 1 |
Candida infection | 1 |
Nausea | 2 |
Atelectasis | 1 |
Dyspepsia | 1 |
Diarrhoea | 2 |
Gastrointestinal Pain | 1 |
Small bowel obstruction | 1 |
Weight loss | 1 |
Chest infection | 1 |
Hypoxia | 1 |
Neutropenia | 1 |